Expired activity
Please go to the PowerPak
homepage and select a course.
Making Sense of the New World of Myeloma Care: Pharmacy Perspectives on Novel Antibodies and BCMA CAR-T Therapy
This CPE activity is provided by Medical Learning Institute, Inc.
This activity is developed with our educational partner, PVI, PeerView Institute for Medical Education.
This educational activity is supported through educational grants from Bristol Myers Squibb, GlaxoSmithKline, and Sanofi Genzyme.
Activity Description
In this activity, a panel of pharmacy experts in multiple myeloma management discusses the latest evidence on novel antibody and CAR-T options and link key take-homes from the data to core aspects of pharmacy practice, from minimizing adverse events/drug interactions to educating patients and staff while addressing other pharmacy considerations.
Target Audience
This activity has been designed to meet the educational needs of hematology-oncology pharmacists, pharmacy managers, and other relevant pharmacy and multidisciplinary hematology-oncology professionals involved in the care of patients with multiple myeloma.
Educational Objectives
Upon completion of this activity, participants will be able to:
- Identify the current treatment role and regulatory status of novel antibodies and cell-based therapy for multiple myeloma
- Summarize efficacy and safety evidence related to the use of CD38, SLAMF7, and BCMA-targeting antibodies and BCMA CAR-T therapy in newly diagnosed and relapsed multiple myeloma
- Develop educational plans for staff and patients surrounding safety, dosing, and potential drug interactions associated with novel antibodies and cell therapy in multiple myeloma
- Apply team-based management strategies for the integration of novel antibodies and cell therapy into existing treatment protocols for multiple myeloma, including addressing formulary concerns or developing intrainstitutional therapeutic algorithms
Continuing Pharmacy Education
Medical Learning Institute, Inc. (MLI) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Medical Learning Institute, Inc. designates this continuing education activity for 1.0 contact hours (0.1 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: 0468-9999-21-011-H01-P
Type of Activity: Application
Time to Complete Activity: 60 minutes
Media: Enduring Material
Release Date
May 12, 2021
Expiration Date
May 11, 2022
Faculty Disclosures
Chair & Presenter
R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA
Professor, Hematology/Medical Oncology and Pharmacology and Chemical Biology
Emory University School of Medicine
Medical Director, Clinical Trials Office
Director, Phase I Clinical Trials Section
Winship Cancer Institute of Emory University
Atlanta, Georgia
R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for Amgen Inc. and GlaxoSmithKline.
Grant/Research Support from Abbisko Therapeutics Co., Ltd.; AbbVie Inc.; Actuate Therapeutics, Inc.; Alkermes; Amgen Inc.; AstraZeneca; Bayer Corporation; Boston Biomedical Inc.; Bristol Myers Squibb; Calithera Biosciences, Inc.; FUJIFILM; Genmab A/S; GlaxoSmithKline; Infinity Pharmaceuticals, Inc.; Inhibrx, Inc.; Janssen Pharmaceuticals, Inc.; Lycera; Merck & Co., Inc.; Mersana Therapeutics; Meryx; Nektar; Pfizer; Puma Biotechnology, Inc.; RAPT Therapeutics; Regeneron Pharmaceuticals Inc.; Rgenix Inc.; Sanofi; Seattle Genetics, Inc.; Sutro Biopharma, Inc.; Takeda Pharmaceutical Company Limited; and Xencor, Inc. Research funding to institution.
Presenter
Kathryn Maples, PharmD, BCOP
Clinical Pharmacy Specialist, Multiple Myeloma
Winship Cancer Institute of Emory University
Atlanta, Georgia
Kathryn Maples, PharmD, BCOP, has a financial interest/relationship or affiliation in the form of:
Consultant and/or Advisor for GlaxoSmithKline; Karyopharm Therapeutics; and Sanofi.
Presenter
Tim J. Peterson, PharmD, BCOP
Clinical Pharmacy Specialist, Multiple Myeloma
Memorial Sloan Kettering Cancer Center
New York, New York
Tim J. Peterson, PharmD, BCOP, has no relevant financial relationship(s) with ineligible companies to disclose for this educational activity.
Planning Committee and Content/Peer Reviewers
The planners and content/peer reviewers from Medical Learning Institute, Inc., the accredited provider, and PVI, PeerView Institute for Medical Education, our educational partner, do not have any relevant financial relationship(s) to disclose with ineligible companies unless listed below.
All of the relevant financial relationships of individuals for this activity have been mitigated.
Disclosure of Unlabeled Use
This educational activity may contain discussions of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this accredited CE activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this accredited CE activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Method of Participation
Participants must 1) read the learning objectives and faculty disclosures; 2) view the educational activity in its entirety; and 3) complete the posttest and evaluation form directly after the activity within a maximum of 60 days of participating in the activity. To answer the questions, click on your selected choice for each answer then proceed to the next question. Once completed, click on the Grade Exam button at the bottom of the page. Your posttest will automatically be graded. If you successfully complete the posttest (score of 70% or higher), your statement of participation will be made available immediately. Click on the View Statement of Participation link and print the statement for your records. If you receive a score lower than 70%, you will receive a message notifying you that you did not pass the posttest. You will have 2 opportunities to pass the posttest. To receive Credit, you must provide your date of birth and NABP number. All Credit information will be uploaded into CPE monitor within 30 days.
About This CPE Activity
PVI, PeerView Institute for Medical Education, and Medical Learning Institute, Inc. are responsible for the selection of this activity’s topics, the preparation of editorial content, and the distribution of this accredited CE activity. Our activities may contain references to unapproved products or uses of these products in certain jurisdictions. The preparation of PeerView activities is supported by educational grants subject to written agreements that clearly stipulate and enforce the editorial independence of PVI and Medical Learning Institute, Inc.
The materials presented here are used with the permission of the authors and/or other sources. These materials do not necessarily reflect the views of PeerView or any of its partners, providers, and/or supporters.
